FDG-PET Superior to CT for Predicting Melanoma Relapse After Immunotherapy

Most patients with a partial response (PR) on a computed tomography (CT) scan and a complete metabolic response (CMR) on a fluorodeoxyglucose (FDG)-positron emission tomography (PET) scan should be considered to have achieved complete response and at low risk for relapse of melanoma, according to research, per Dermatology Advisor.